Open AccessRadiographic Hepatic Steatosis Is Not Associated With Key Clinical Outcomes Among Patients Hospitalized With COVID-19
Author(s) -
Hirsh D. Trivedi,
Robert M. Wilechansky,
Daniela Goyes,
Joana Vieira Barbosa,
Andrew Canakis,
Michelle Lai,
Michelle T. Long,
Zachary Fricker
Publication year - 2021
Publication title -
gastroenterology research
Language(s) - English
Resource type - Journals
eISSN - 1918-2813
pISSN - 1918-2805
DOI - 10.14740/gr1389
Subject(s) - medicine , steatosis , intensive care unit , odds ratio , mechanical ventilation , confounding , confidence interval , retrospective cohort study , intensive care , gastroenterology , intensive care medicine
Metabolic syndrome increases adverse outcomes in coronavirus disease 2019 (COVID-19) infection. Hepatic steatosis may increase risk of COVID-19 severity. Current studies evaluating steatosis lack reliable definitions. We aimed to evaluate the association of radiographic hepatic steatosis and clinical outcomes of COVID-19 severity in a diverse cohort.